- Further detail from G306 Phase III field trial
- Director Resignation
- Interim Results for six months ended 31 Dec 2023
- Update on funding
- VLP Peanut PROTECT Trial Update
- VLP Peanut PROTECT Trial Update
- Appointment of Shaun Furlong to Board of Directors
- Result of AGM
- Half-Year Trading Update 2024
- Notice of 2023 Annual General Meeting
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.40 |
---|---|
High | 3.40 |
Low | 3.40 |
Bid | 3.30 |
Offer | 4.00 |
Previous close | 3.30 |
Average volume | 1.05m |
---|---|
Shares outstanding | 4.77bn |
Free float | 323.44m |
P/E (TTM) | -- |
Market cap | 157.29m GBP |
EPS (TTM) | -0.0266 GBP |
Data delayed at least 20 minutes, as of May 23 2024 16:35 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Allergy Therapeutics PLC shares was Hold at 13.00 on 25 Sep 2019Read the full article